5a13be122b
Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
5.7 KiB
5.7 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Health Care - As enacted, adds nonopioid medicinal drugs or drug products, occupational therapy, and interventional procedures or treatments to the alternative treatments that must be disclosed and explained by a healthcare practitioner to a patient or the patient's legal representative as a prerequisite to obtaining informed consent to treatment with an opioid. - Amends TCA Section 63-1-164. | Health Care - As enacted, adds nonopioid medicinal drugs or drug products, occupational therapy, and interventional procedures or treatments to the alternative treatments that must be disclosed and explained by a healthcare practitioner to a patient or the patient's legal representative as a prerequisite to obtaining informed consent to treatment with an opioid. - Amends TCA Section 63-1-164. | us/states/tn | Tennessee General Assembly | 111 | SB 1912 | Tennessee SB 1912 (111) |
|
|
enacted |
|
3 | 33 | 6 | 2020-01-27 | 2020-03-26 | openstates | ocd-bill/ab88047c-8af8-4ba9-ac65-a15dbdefb0f4 | http://wapp.capitol.tn.gov/apps/BillInfo/default.aspx?BillNumber=SB1912&GA=111 | 676a1b81d340db64e0774951cb60b0bc3ccb907512989b6eff53e92fb90643d5 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Tennessee SB 1912 (111) — Health Care - As enacted, adds nonopioid medicinal drugs or drug products, occupational therapy, and interventional procedures or treatments to the alternative treatments that must be disclosed and explained by a healthcare practitioner to a patient or the patient's legal representative as a prerequisite to obtaining informed consent to treatment with an opioid. - Amends TCA Section 63-1-164.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Amendment HA0559 (committee substitute) — source
- Amendment SA0500 (committee substitute) — source
- Current Version (committee substitute) — source
Votes
- FLOOR VOTE: as Amended Third Consideration 2/24/2020 Passed (1) — 29–0 (pass) · upper
- HOUSE MENTAL HEALTH & SUBSTANCE ABUSE SUBCOMMITTEE: Rec for pass if am by s/c ref. to Health Committee 2/19/2020 — 0–0 (fail) · lower
- FLOOR VOTE: REGULAR CALENDAR PASSAGE ON THIRD CONSIDERATION 3/5/2020 Passed (1) — 88–0 (pass) · lower
- SENATE HEALTH AND WELFARE COMMITTEE: Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 9, Nays 0 PNV 0 2/19/2020 Passed — 9–0 (pass) · upper
- HOUSE HEALTH COMMITTEE: Rec. for pass. if am., ref. to Calendar & Rules Committee 2/25/2020 — 0–0 (pass) · lower
- HOUSE CALENDAR & RULES COMMITTEE: H. Placed on Regular Calendar for 3/5/2020 2/27/2020 (2) — 0–0 (fail) · lower
Sponsors
- Reeves — primary (person)
- Vaughan — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2020-01-27 Filed for introduction
reading-1, introduction - 2020-01-28 Filed for introduction
reading-1, introduction - 2020-01-29 Introduced, Passed on First Consideration
introduction - 2020-01-29 Intro., P1C.
introduction - 2020-01-30 Passed on Second Consideration, refer to Senate Health and Welfare Committee
- 2020-01-30 P2C, ref. to Health Committee
referral-committee - 2020-01-31 Assigned to s/c Mental Health & Substance Abuse Subcommittee
referral-committee - 2020-02-12 Placed on Senate Health and Welfare Committee calendar for 2/19/2020
- 2020-02-12 Placed on s/c cal Mental Health & Substance Abuse Subcommittee for 2/19/2020
- 2020-02-19 Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 9, Nays 0 PNV 0
- 2020-02-19 Recommended for passage, refer to Senate Calendar Committee
- 2020-02-19 Placed on cal. Health Committee for 2/25/2020
- 2020-02-19 Rec for pass if am by s/c ref. to Health Committee
referral-committee - 2020-02-20 Placed on Senate Regular Calendar for 2/24/2020
- 2020-02-24 Passed Senate as amended, Ayes 29, Nays 0
passage - 2020-02-24 Senate adopted Amendment (Amendment 1 - SA0500)
- 2020-02-25 Engrossed; ready for transmission to House
- 2020-02-25 Rec. for pass. if am., ref. to Calendar & Rules Committee
committee-passage-favorable - 2020-02-26 Placed on cal. Calendar & Rules Committee for 2/27/2020
- 2020-02-27 Rcvd. from S., held on H. desk.
- 2020-02-27 H. Placed on Regular Calendar for 3/5/2020
- 2020-03-05 Passed H., Ayes 88, Nays 0, PNV 0
passage - 2020-03-05 Am. withdrawn. (Amendment 1 - HA0559)
amendment-withdrawal - 2020-03-05 Subst. for comp. HB.
- 2020-03-05 Comp. SB subst.
- 2020-03-09 Signed by Senate Speaker
- 2020-03-09 Enrolled and ready for signatures
- 2020-03-10 Transmitted to Governor for action.
- 2020-03-10 Signed by H. Speaker
- 2020-03-19 Signed by Governor.
executive-signature - 2020-03-26 Pub. Ch. 573
- 2020-03-26 Effective date(s) 03/19/2020
- 2020-03-26 Comp. became Pub. Ch. 573
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/ab88047c-8af8-4ba9-ac65-a15dbdefb0f4. Confidence: reported (aggregated from official Tennessee legislature records).